Loading clinical trials...
Loading clinical trials...
e-SEP Cognition: Effectiveness of a Remediation Program Via a "Serious Game" on the Cognitive Functions of Multiple Sclerosis Patients: Controlled, Randomized, Multicentric Trial
The main goal of this study is to assess the effectiveness of a cognitive remediation program based on a "serious game" on the information processing speed evolution and the process of learning via episodic memory in multiple sclerosis patients.
Cognitive impairment affects 40 to 70% multiple sclerosis patients. This condition is characterized by slower information processing, associated with deficits in episodic memory, attention and executive functions. These disorders appear early, regardless of functional impairment, in "benign" forms and in clinically isolated syndromes of multiple sclerosis. These disruptions can have a significant impact in the socio-professional and personal life of patients and also in the quality of life (job loss risks, daily activities limitations). Even if these disorders are now well documented, remediation strategies remain less studied. Some studies show that the "training" methods, often used, do not seem suitable for clinical monitoring, with benefits that do not persist over time. Despite their impact on daily life, no specific care for planning abilities, mental inhibition and flexibility, or even social cognition, have been well studied until today. The same is true concerning metacognitive abilities. Finally, remedial techniques are time consuming and difficult to adapt to patients still in professional activity.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
CH Arras
Arras, Hauts-de-France, France
CH LENS
Lens, Hauts-de-France, France
CHRU
Lille, Hauts-de-France, France
Saint Vincent hospital
Lille, Hauts-de-France, France
Saint-Philibert hospital
Lomme, Nord, France
Charles Nicolle Hospital
Rouen, Normandy, France
Start Date
October 8, 2021
Primary Completion Date
April 4, 2026
Completion Date
March 1, 2027
Last Updated
September 4, 2025
150
ESTIMATED participants
Serious game
DIAGNOSTIC_TEST
Usual HAS care
DIAGNOSTIC_TEST
Lead Sponsor
Lille Catholic University
NCT06276634
NCT07225504
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06809192